Obesity; Endocrine
19
1
3
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 19 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (19)
Effect of Protein Source During Ketogenic Weight Loss Intervention
Study of Lipolysis of Visceral Reserve Fat Using Tecar Therapy.
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Obesity
Energy Metabolism and Acute Effects of Protein Diets in Metabolically Obese Normal Weight Individuals
NEUROENDOCRINE REGULATION OF BONE-FAT CROSSTALK IN OBESITY
The Effect of White Tea Consumption on Obesity
Vitamin D and Its Metabolites Quantification in Adipose Tissues of Obese and Non-obese Patients.
Data Mining: Precision Analytical Retrospective Data Correlation
Probiotic Blend in Reducing Anthropometric Measurements in Obese Adults
Molecular, Metabolomic and Nutritional Changes After Metabolic Surgery
Time-restricted Eating and High Intensity Interval Training Among Women
Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy - Part 2
Female Obesity Cohort and Intervention Study Group (MOCART Study Group)
Study on the Mechanism of lcn2 in Obesity
Life Style Modification Medical and Surgical Management in Patients With Obesity
Acute and Chronic Metabolic Flexibility in Individuals Living With Obesity: The i-FLEX Study
Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy
C1q/TNF-related Protein 9 (CTRP 9) Level in Preeclamptic Obese and Non-obese Pregnancies
The "Metabolically-obese Normal-weight" Phenotype and Its Reversal by Calorie Restriction